openPR Logo
Press release

Invite from Ziva Abraham, Chair at SMi's 3rd Annual Pharma Microbiology West Coast Conference 2019

04-16-2019 01:26 PM CET | Health & Medicine

Press release from: SMi Group

Pharmaceutical Microbiology West Coast 2019

Pharmaceutical Microbiology West Coast 2019

The highly anticipated Pharmaceutical Microbiology West Coast Conference is returning to San Diego, USA, this June.

SMi Group are pleased to have Ziva Abraham, CEO, Microrite, Inc. as the chair for the two-day conference. Ziva Abraham is the President and Founder of Microrite, Inc., a California based consulting firm providing consulting and training services to pharmaceuticals, biotechnology, medical devices and in vitro diagnostics in the areas of quality assurance, quality control, microbiology, and validation.

Read Ziva’s invitation to the conference below:

“Since the release of the agenda for SMi’s 3rd Annual Pharmaceutical Microbiology West Coast, I am delighted to share with you the updated brochure with more speakers and a packed agenda for the two-day conference taking place on June 5th and 6th, 2019 at the Hyatt Regency Mission Bay Hotel in San Diego, CA, USA.

Pharmaceutical microbiology has extended from the laboratory and into the production environment at a rapid pace. Just a decade ago, QC microbiologists had just one function: performing QC microbiology testing. We are at a tipping point where pharmaceutical microbiologists need to have an understanding of, and the ability to, implement microbiological quality control from facility design to final product release. There is no better discipline or department in sterile or non-sterile manufacturing than microbiology to handle this task. But, in order to equip ourselves with knowledge and tools to carry out this formidable role we must learn and expand our knowledge in the areas of cleanroom design and qualification, the manufacturing process as well as production.

To meet current regulatory thinking and expectations on contamination control as a key component of quality, the role of the microbiologist is more crucial than ever before.

The field of pharmaceutical microbiology is evolving at a fast pace. There is a higher sense of awareness, of microbial contamination risks and the clinical implications of microbes, by regulators and manufacturers alike.

The West Coast 2019 agenda is filled with exciting topics and speakers who have extensive experience including facing multiple audits as microbiologists or quality personnel. There is no better way to learn and meet current demands than to absorb this knowledge from those who have evolved in their roles from QC microbiologists into contamination control and quality professionals over years facing regulators and enhancing microbial control standards at their respective organizations.

As the chair of this conference, I personally look forward to welcoming you to the event this June in San Diego!”

Download the updated event brochure with the full agenda and speaker line-up at http://www.pharma-microbiology-usa.com/PR3

Plus, there are two pre-conference workshops taking place on Tuesday, June 4th, 2019:

Workshop A is led by Ziva Abraham, CEO, Microrite, Inc. on the topic of ‘Assessing a Holistic Approach to Microbial Contamination Control’

Workshop B is led by Friedrich von Wintzingerode, Senior Manager gASAT Microbiology, Global QC, Genentech & Farnaz Nowroozi, Scientist & Manager, Genentech on the topic of ‘Reviewing the Road Map to a Holistic Approach to Microbial Impurities, Endotoxins & LER’

The last early bird discount of $100 is expiring on Tuesday, April 30th, 2019. Register soon to guarantee a place at http://www.pharma-microbiology-usa.com/PR3

THE EVENT IS SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm & Microbiologics

If you are interested in sponsoring, exhibiting or speaking at this event, please contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pharmaceutical Microbiology West Coast
Conference: June, 5 - 6 June 2019
Workshops: June, 4 2019
Hyatt Regency Mission Bay Hotel, CA, USA
http://www.pharma-microbiology-usa.com/PR3
#SMiPharmaMicroUSA

---- END ---

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Group Ltd
Registered & Head Office: SMi Group Ltd, India House, 45 Curlew Street, London, SE1 2ND
Contact Simi Sapal on ssapal@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Invite from Ziva Abraham, Chair at SMi's 3rd Annual Pharma Microbiology West Coast Conference 2019 here

News-ID: 1705176 • Views:

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases


More Releases for Pharmaceutical

Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis: The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers. The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North